Literature DB >> 9355915

Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice.

C Shi1, W S Lee, M E Russell, D Zhang, D L Fletcher, J B Newell, E Haber.   

Abstract

BACKGROUND: Hypercholesterolemia is thought to be a significant risk factor for coronary vasculopathy in cardiac transplant recipients. METHODS AND
RESULTS: We examined the development of arteriosclerosis in mouse carotid artery loops allografted from B.10A(2R) (H-2h2) donors to normocholesterolemic C57BL/6J (H-2h) recipients and hypercholesterolemic C57BL/6J recipients in which the apolipoprotein (apo) E gene had been knocked out. Luminal occlusion and cross-sectional neointimal area were greater in arteries allografted into hypercholesterolemic recipients at 15 and 30 days after transplantation. We also measured cellular and extracellular matrix components of the neointima by computerized planimetry of the fractional areas subtended by smooth muscle cells (anti-alpha-actin stain), collagen (Masson's trichrome), lipid (oil red O), and leukocytes (anti-CD45). The neointimal area stained for smooth muscle cells was significantly greater in hypercholesterolemic recipients than in normocholesterolemic recipients at 15 and 30 days after allografting. Lipid contributed to neointimal area to a lesser degree, and there was no significant increase in the contribution of collagen or leukocytes.
CONCLUSIONS: Smooth muscle cell accumulation appears to be the principal contributor to the increase in neointimal area observed in arteries allografted into hypercholesterolemic mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355915     DOI: 10.1161/01.cir.96.8.2722

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: current practice and future directions.

Authors:  Clifford Chin; Daniel Bernstein
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.

Authors:  B Zhu; D G Kuhel; D P Witte; D Y Hui
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Hyperlipidemia Alters Regulatory T Cell Function and Promotes Resistance to Tolerance Induction Through Costimulatory Molecule Blockade.

Authors:  J Bagley; J Yuan; A Chandrakar; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

4.  Hyperlipidemia Promotes Anti-Donor Th17 Responses That Accelerate Allograft Rejection.

Authors:  J Yuan; J Bagley; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

5.  Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors.

Authors:  K Pethig; V Klauss; B Heublein; H Mudra; A Westphal; C Weber; K Theisen; A Haverich
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 6.  Management of hyperlipidaemia associated with heart transplantation.

Authors:  Klaus Wenke
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Reduced transplant arteriosclerosis in plasminogen-deficient mice.

Authors:  L Moons; C Shi; V Ploplis; E Plow; E Haber; D Collen; P Carmeliet
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

8.  Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.

Authors:  Alexandru Schiopu; Satish N Nadig; Ovidiu S Cotoi; Joanna Hester; Nico van Rooijen; Kathryn J Wood
Journal:  Atherosclerosis       Date:  2012-05-19       Impact factor: 5.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.